Format

Send to

Choose Destination
Nature. 1990 Sep 13;347(6289):146-51.

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Author information

1
Unité de Neurobiologie et Pharmacologie (U. 109) de l'INSERM, Paris, France.

Abstract

A dopamine receptor has been characterized which differs in its pharmacology and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor. The D3 receptor is localized to limbic areas of the brain, which are associated with cognitive, emotional and endocrine functions. It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.

PMID:
1975644
DOI:
10.1038/347146a0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center